TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
4 hedge funds and large institutions have $42.6K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
83% less capital invested
Capital invested by funds: $244K → $42.6K (-$201K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$28K |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$22.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$500 |
| 4 |
HT
Headlands Technologies
Chicago,
Illinois
|
+$250 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$235K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.78K |
| 3 |
JP Morgan Chase
New York
|
-$282 |
TCBP Hedge Fund Activity: Q1 2024 in Review
4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q1 2024, worth a combined $42.6K — down 83% from $244K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TCBP positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $28K. The largest seller was Armistice Capital, exiting entirely with an estimated $235K sold.
- 4 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $42.6K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q1 2024, down 83% quarter-over-quarter.
- 4 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q1 2024 and 3 closed out, a net change of +1 holder.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q1 2024 was Virtu Financial, an estimated $28K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q1 2024 was Armistice Capital, an estimated $235K sold.
Based on aggregated 13F filings for Q1 2024.